A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a multicenter, randomized, open-label, phase 3 clinical study to evaluate the efficacy of SHR-A1912 combined with R-GemOx in relapsed refractory diffuse large B-cell lymphoma.
Epistemonikos ID: 3e3c2dc29d0b3cc85101d607507caff74fa47db2
First added on: Apr 17, 2025